Navigation Links
ResMed Takes Action to Enforce Patents
Date:3/28/2013

SAN DIEGO, March 28, 2013 /PRNewswire/ -- ResMed, an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions, has filed parallel legal actions in the International Trade Commission (ITC) and in U.S. federal court to stop the infringement of ResMed patents.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

ResMed filed the actions against Taiwanese manufacturer APEX Medical and its U.S. distributor, Medical Depot, Inc., doing business as Drive Medical Design and Manufacturing. ResMed alleges that multiple ResMed patents are infringed by several APEX products, including:

  • The APEX WiZARD 210 and WiZARD 220 masks
  • The identical Freedom 210 and Freedom 220 masks made by APEX and sold by Medical Depot
  • The APEX iCH and XT Fit flow generators
  • ResMed is asking the ITC to stop the importation and sales of these products in the United States, and it is asking the U.S. federal court to stop the infringement and award damages against the defendants.

    "For more than two decades, ResMed has generated significant advances in innovative products for sleep-disordered breathing therapy," said ResMed global general counsel and chief administrative officer David Pendarvis . "We invest over a hundred million dollars in research and development each year to fuel these advances and other companies should not be allowed to infringe ResMed's intellectual property by using our technology."

    About ResMed:
    ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those w
    '/>"/>

    SOURCE ResMed Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
    2. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
    3. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
    4. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
    5. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
    6. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
    7. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
    8. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
    9. In basic science, sometimes it takes individual benefactors like Roys Poyiadjis to fuel innovation
    10. HealthClubExperts.com Takes Aim at Youth Obesity, Set to Launch Youth Fitness Equipment
    11. Rivalz Sports Group, Inc Sportstalk Station WRSO 810 AM Orlando Officially Takes Over And Goes Live With Sports Programming
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/1/2015)... , Sept. 1, 2015 ... held a press conference in Taipei ... in its new Vaucarrin™ platform, a targeted drug delivery ... This event was part of a joint ... Gold NanoTech Inc. (GNT), showcasing GNT,s latest edible ...
    (Date:9/1/2015)... Sept. 1, 2015   Ivenix Inc. , ... management system, closed on a $42M round of ... Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, Fidelity ... the round. This financing will support the company,s ... Leerink Partners LLC acted as the exclusive placement ...
    (Date:9/1/2015)... , Sept. 1, 2015 CytRx Corporation ... development company specializing in oncology, today announced that ... Executive Officer, and David Haen , Vice ... present a corporate overview at two significant investment ... and healthcare industries: the FBR & Co. Second ...
    Breaking Medicine Technology:GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 2CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 3CytRx Announces Participation at FBR & Co. Second Annual Health Conference and Rodman & Renshaw 17th Annual Global Investment Conference 4
    ... - Potential First-in-Class Treatment for Type 2 Diabetes ... Inc., a,biopharmaceutical company focused on the discovery and ... metabolic diseases,announced today that it has dosed the ... clinical trial of MBX-2982, a potential first-in-class treatment,for ...
    ... 25 ExonHit Therapeutics, a drug,and diagnostic discovery ... 1,study assessing the effects of its lead compound, ... EHT 0202 is a,compound, with a novel mechanism ... and neuronal loss and is currently tested in ...
    Cached Medicine Technology:Metabolex Initiates Phase 1 Trial of MBX-2982 2ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans 2ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans 3ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans 4
    (Date:9/1/2015)... ... 2015 , ... Negative pressure wound therapy (NPWT) entails the ... exudates, fluid, and infectious materials to prepare the wound for healing and closure. ... canisters, etc.) is projected to expand continuously through 2021. , Rising patient and ...
    (Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in Houston, TX ... , an innovative vaginal health laser procedure that prevents and resolves dryness in ... atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful intercourse and ...
    (Date:9/1/2015)... ... September 01, 2015 , ... ... Screeners (NAPBS®) has announced that Edge Information Management has been granted ... Background Screening Credentialing Council (BSCC). , “Achieving and maintaining this accreditation ...
    (Date:9/1/2015)... Burlington, MA (PRWEB) , ... September 01, 2015 ... ... for remote real-time monitoring and analysis of pet vital signs and activity, today ... Cornerstone is one of the most popular and widely-adopted veterinary hospital Practice Management ...
    (Date:9/1/2015)... ... September 01, 2015 , ... Discovia, ... entities, announced today that it has hired Scott Sanderson, an experienced business development ... capacity, Sanderson will be responsible for establishing and managing new client relationships in ...
    Breaking Medicine News(10 mins):Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2
    ... second year in a row, survivors and generous souls alike ... Thriving Breast Fest Burlesque Show and Auction supporting the You ... burlesque show, silent auction and raffle, will take place on ... Hill,s in SoHo (511 Greenwich Street, NY). , All proceeds ...
    ... is one of five academic medical centers in the ... the University HealthSystem Consortium (UHC). The prestigious award is ... high-quality care, as measured by the UHC Quality and ... year, 93 member hospitals were ranked by UHC, a ...
    ... exists, experts say, , FRIDAY, Oct. 2 (HealthDay News) -- ... earlier treatment can begin. On that, experts agree. , ... odds of developing the degenerative brain disorder -- including some ... to figure it out: Do you or don,t you have ...
    ... Oct. 2 Amicus Therapeutics (Nasdaq: FOLD ) ... open-label study to assess the safety, tolerability and preliminary ... treatment-naive adult patients with type 1 Gaucher disease. ... on/four days off and seven days on/seven days off) ...
    ... long way in the last decade. Today, one can talk, text ... access the Web. Now imagine a cell phone that can be ... water quality after a major disaster like a hurricane or earthquake. ... at UCLA,s Henry Samueli School of Engineering and Applied Science, has ...
    ... remarkable history, role of dentists and reaffirms patient advocacy ... (ADA) yearlong observance of its 150th birthday will culminate with ... Waikiki Shell. , "The ADA,s 150th anniversary is a very ... Association," said ADA President John S. Findley, D.D.S. "It ...
    Cached Medicine News:Health News:You Can Thrive! Burlesque Show Celebrates the Girls and the Women Who Are Battling to Keep Them 2Health News:University Hospitals Case Medical Center earns prestigious national award for excellence 2Health News:Uncertainty Surrounds Testing for Alzheimer's 2Health News:Uncertainty Surrounds Testing for Alzheimer's 3Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 2Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 3Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 4Health News:Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease 5Health News:NIH recognizes engineering professor's innovative research with major award 2Health News:NIH recognizes engineering professor's innovative research with major award 3Health News:ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 2Health News:ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 3
    Kleinert-Kutz Single Skin Hook, Large...
    Designated most popular model or size....
    Gillies (Converse) Skin Hook, small hook size....
    The Accuref 8001 allows you to measure much smaller pupils than conventional units and 3 step Target light adjuster ensures accurate results....
    Medicine Products: